Omnipod® 5 Frequently Asked Questions

The Omnipod® 5 System is the first wearable, on-body, tubeless, hybrid closed loop system integrated with Dexcom G6, approved in Europe for use in people with Type 1 diabetes, aged 2 and above. The Omnipod 5 System works with the Dexcom G6 Continuous Glucose Monitoring System to continuously adapt and automatically deliver insulin according to the user's personal needs.

We will start bringing out Omnipod® 5 in the middle of 2023 in the first countries in Europe and thereafter on a country by country basis. We are excited to have reached the first milestone of CE marking and can now begin working on securing reimbursment and access. We will confirm timings in advance of product availability.

Register your interest with your sales representative or here, to receive all relevant information and be contacted when training starts in advance of product availability in your country.

Choice and access to technology for people living with Type 1 diabetes is of the upmost importance for Insulet, and so we will continue to supply both Omnipod DASH® and Omnipod® 5, recognising the needs and preferences of HCPs and people living with diabetes.

As we work to get Omnipod® 5 ready in your country, your patients are able to register their interest here.